arthritis: search

Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

New report: Arthritis is a potential barrier to physical activity for adults with diabetes

Atlanta, GA – May 8, 2008 – People with diagnosed diabetes are nearly twice as likely to have arthritis, and the inactivity caused by arthritis hinders the successful management of both diseases, according to a new Morbidity and Mortality Weekly Report (MMWR) study released today by the Centers for Disease Control and Prevention (CDC). This is one of the first studies of its kind to look at the relationship between arthritis and diabetes and the outcomes associated with physical activity.

Arthritis Immunology - Researchers from Nanjing University, Department of Biochemistry publish findings in arthritis immunology

VerticalNews Agriculture -- VerticalNews Chemicals & Chemistry -- VerticalNews China -- VerticalNews Computers -- VerticalNews Defense & Aerospace -- VerticalNews Ecology, Environment & Conservation -- VerticalNews Economics -- VerticalNews Education -- VerticalNews Electronics -- VerticalNews Energy -- VerticalNews Engineering -- VerticalNews Entertainment -- VerticalNews Food -- VerticalNews Global Warming -- VerticalNews Health -- VerticalNews India -- VerticalNews Information Technology -- VerticalNews Insurance -- VerticalNews Internet -- VerticalNews Investment -- VerticalNews Leisure & Travel -- VerticalNews Marketing -- VerticalNews Mathematics -- VerticalNews Mergers & Acquisitions -- VerticalNews Mining & Minerals -- VerticalNews Nanotechnology -- VerticalNews Networks -- VerticalNews Physics -- VerticalNews Politics & Governmen

Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

The Healthcare Sales & Marketing Network(R): Sales & Marketing News, Information and Networking for Medical Devices, Pharmaceuticals and Biotechnology.

Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

Extensive Clinical Development Program Investigating Golimumab in the Treatment of These Diseases Serves as Basis for the Application HORSHAM, Pa., June 27

Oily Fish Can Protect Against Rheumatoid Arthritis, But Smoking And Psychosocial Stress Increase Its Risk

New data presented June 13 at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France, show that intake of oily fish is associated with a reduced risk of developing rheumatoid arthritis (RA), whereas psychosocial work stress and smoking can increase the risk of developing the condition.

Novel DNA Microarray Chip Predicts Functional Impairment And Remission In Rheumatoid Arthritis

A new DNA microarray chip can predict severe disability and remission in patients with rheumatoid arthritis (RA), as presented today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France. The chip (called the 'ARTchip') has yielded two clinical-genetic models of RA outcomes, to assist physicians in anticipating likely disease progression and prognosis and thereby guide decisions on the best course of treatment for individual patients.

Novel DNA microarray chip predicts functional impairment and remission in rheumatoid arthritis

Paris, France, Friday 13 June 2008: A new DNA microarray chip can predict severe disability and remission in patients with rheumatoid arthritis (RA), as presented today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France. The chip (called the 'ARTchip') has yielded two clinical-genetic models of RA outcomes, to assist physicians in anticipating likely disease progression and prognosis and thereby guide decisions on the best course of treatment for individual patients.

ACTRA: Copyright Reform A Good First Step

New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis

Gene Sweeps Yield Discoveries

New York -- Scientists are scanning human DNA with a precision and scope once unthinkable and rapidly finding genes linked to cancer, arthritis, diabetes and other diseases.

EntreMed Receives New Patent for 2-Methoxyestradiol Analogs

PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the issuance of U.S. Patent No. 7,371,741 covering analogs of 2- methoxyestradiol (2ME2). The patent grants EntreMed composition-of-matter and method of use intellectual property protection through 2025 for analogs of 2ME2 in oncology and a broad range of non-oncology indications, including inflammatory and immune disorders, rheumatoid arthritis, and other diseases characterized by abnormal cell division (mitosis).

Search took 0.01 seconds.